Sales and Adjusted Earnings Expected to Exceed Prior Guidance
GAAP EPS Expected to be $0.72 to $0.78 and Adjusted EPS $1.01 to $1.05
Company Plans to Report Fourth
Sleep Number (NASDAQ:SNBR) reported quarterly earnings of $0.88 per share which missed the analyst consensus estimate of $1.07 by 17.76 percent. This is a 295.56 percent increase over losses of $(0.45) per share from the
Ultomiris, the successor to Alexion Pharmaceuticals Inc's (NASDAQ: ALXN) paroxysmal nocturnal hemoglobinuria (PNH) drug Soliris, is on track for another blockbuster year.
Telenor ASA (OTC: TELNY) reported a second-quarter FY21 revenue decline of 6.3% year-on-year to about $3.01 billion (NOK 27.2 billion). (1$ = 9.05 Norwegian Krone as of July 20).
Pacific Biosciences of California Inc (NASDAQ:PACB) has agreed to acquire Omniome, a San Diego-based company developing a short-read sequencing platform. …
On the day Amazon (NASDAQ: AMZN) founder Jeff Bezos launches himself into space, most investors would probably be happy just to see the major indices pick themselves off the carpet after yesterday’s meltdown.